Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

A variety of inflammatory facial dermatoses, such as papulopustular rosacea and perioral dermatitis, are often idiopathic. However, prolonged continuous and/or repeated intermittent topical corticosteroid use can exacerbate these disorders or, in some cases, induce them. This article discusses corticosteroid-induced rosacea-like dermatitis and primary perioral dermatitis with regard to clinical presentations, including in both adults and children, and management considerations. The rationale for use of an anti-inflammatory dose of doxycycline that is subantimicrobial, doxycycline modified-release 40mg capsule once daily, along with properly selected skin care, is discussed. Case illustrations are also included.